Higher Dietary Polyphenol Intake Linked to Lower Likelihood of Mild Cognitive Impairment in Older Adults

As global populations age, protecting cognitive health has emerged as a major public health priority. A recent study published in the journal Antioxidants investigates whether habitual consumption of plant compounds known as polyphenols is associated with a reduced likelihood of early cognitive decline in older adults. Conducted by researchers in Italy, the study examines how specific dietary patterns and antioxidant-rich foods relate to mild cognitive impairment.

Understanding the Growing Burden of Cognitive Impairment

Global demographic shifts indicate that by the year 2050, more than 21% of the world’s population will be aged 60 or older. Alongside this longevity boom, conditions affecting brain health, such as dementia, are projected to expand significantly, climbing from an estimated 55 million affected individuals worldwide to nearly 139 million by mid-century. While major neurodegenerative conditions like Alzheimer’s disease contribute heavily to this burden, milder states of cognitive reduction—such as mild cognitive impairment (MCI)—affect roughly 15% of community-dwelling adults aged 50 and older.

Because lifestyle habits heavily influence neurological aging, researchers continue to explore how daily nutrition impacts the brain. Plant-rich eating patterns, including the Mediterranean, DASH, and MIND diets, have long been associated with a slower rate of cognitive decline and reduced dementia risk. Experts suggest that these protective benefits may stem from bioactive phytochemicals found in fruits, vegetables, and other plant foods. Among these compounds, polyphenols and flavonoids are known for their antioxidant properties and potential to support cerebral blood flow, neurogenesis, and synaptic plasticity.

Examining Plant Compounds and Memory Health

To better understand the connection between specific plant compounds and early cognitive changes, researchers from the Geriatrics Unit at the IRCCS Oasi Research Institute in Troina, Italy, conducted a cross-sectional study. The investigation enrolled 92 autonomous older adults aged 65 or older who presented with memory complaints at a memory clinic. Participants underwent evaluations to classify their cognitive status, categorizing them into groups with or without mild cognitive impairment.

Long-term dietary habits were evaluated using a validated 110-item food frequency questionnaire. The researchers estimated total dietary polyphenol intake by cross-referencing questionnaire responses with the Phenol-Explorer database, focusing on 75 relevant food items and accounting for food processing and cooking methods. In addition, the participants completed cognitive assessments, mood evaluations, and sleep quality questionnaires, alongside blood draws to measure specific circulating inflammatory biomarkers.

Key Findings on Polyphenols and Cognitive Status

When comparing participants with and without mild cognitive impairment, the investigators observed distinct dietary patterns. Individuals without MCI reported significantly higher estimated average intakes of total dietary polyphenols compared to those diagnosed with MCI. Furthermore, non-MCI participants showed higher reported consumption of specific subclasses, including flavonoids, anthocyanins, flavanones, flavones, hydroxycinnamic acids, and lignans.

At the individual compound level, those without MCI reported greater intake of specific nutrients such as:

• Hesperetin
• Naringenin
• Quercetin
• Lariciresinol
• Secoisolariciresinol
• Matairesinol
• Pinoresinol

Statistical models adjusting for age, sex, educational level, energy intake, and smoking status revealed that individuals with the highest overall intake of polyphenols, flavonoids, and lignans had a lower likelihood of presenting with MCI. Among the flavonoid subclasses, flavones demonstrated the strongest inverse association with cognitive impairment.

Evaluating Inflammatory Markers and Study Limitations

The researchers also analyzed blood plasma concentrations of specific inflammatory markers, such as TGF-beta1 and TNF-alpha, to determine whether reduced systemic inflammation explained the cognitive findings. While higher ratios of these inflammatory factors correlated with lower cognitive scores in participants with MCI, total polyphenol intake was not significantly correlated with overall inflammatory marker levels, and only weak associations appeared with certain individual compounds.

The study’s authors emphasize several limitations. Because the research was cross-sectional, it cannot establish whether a higher intake of dietary polyphenols directly prevents cognitive decline or precedes it. Factors such as potential dietary recall errors, single-point inflammatory measurements, and the observational design mean the findings should be viewed as exploratory. Longitudinal trials and long-term interventional studies are necessary to confirm these relationships and better understand the underlying mechanisms supporting healthy brain aging.

Source: News-Medical.net